Home » Two Genomics Patents for Mass. General Hospital

Two Genomics Patents for Mass. General Hospital

Apr 07, 2000
Premium

R

OCKVILLE, Md.--Two functional genomics and drug discovery patents have been issued to Massachusetts General Hospital and exclusively licensed to Life Technologies here. The patents for the Reverse Two-Hybrid System cover methods and reagents for characterization of large-molecule interactions within organisms. The system is designed to help achieve understanding of cellular mechanisms for the development of more targeted and effective drugs, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

The Apple's Journey

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

This Week in Nature

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Change Is Hard to Do

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

Possible Paths for CUP

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.

What's Popular?

In Informatics

  1. Google Deep Learning May Improve SNP Analysis, But Don't Call It AI Anytime Soon

    Premium

  2. Stanford-Developed Approach Allows for More Private Analysis of Human Genomes

  3. CHOP to Head NIH-Backed Data Center for Pediatric Cancer Research

  4. Geneformics Sees Lossless Compression as Answer to Cloud Genomics

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.